...
首页> 外文期刊>Fluids and Barriers of the CNS >Challenges in cerebrospinal fluid shunting in patients with glioblastoma
【24h】

Challenges in cerebrospinal fluid shunting in patients with glioblastoma

机译:胶质母细胞瘤患者脑脊液分流的挑战

获取原文
           

摘要

Cerebrospinal fluid (CSF) circulation disturbances may occur during the course of disease in patients with glioblastoma. Ventriculoperitoneal shunting has generally been recommended to improve symptoms in glioblastoma patients. Shunt implantation for patients with glioblastoma, however, presents as a complex situation and produces different problems to shunting in other contexts. Information on complications of shunting glioma patients has rarely been the subject of investigation. In this retrospective study, we analysed restropectively the course and outcome of glioblastoma-related CSF circulation disturbances after shunt management in a consecutive series of patients within a period of over a decade. Thirty of 723 patients with histopathologically-confirmed glioblastoma diagnosed from 2002 to 2016 at the Department of Neurosurgery, Hannover Medical School, underwent shunting for CSF circulation disorders. Treatment history of glioblastoma and all procedures associated with shunt implementation were analyzed. Data on follow-up, time to progression and survival rates were obtained by review of hospital charts and supplemented by phone interviews with the patients, their relations or the primary physicians. Mean age at the time of diagnosis of glioblastoma was 43?years. Five types of CSF circulation disturbances were identified: obstructive hydrocephalus (n?=?9), communicating hydrocephalus (n?=?15), external hydrocephalus (n?=?3), trapped lateral ventricle (n?=?1), and expanding fluid collection in the resection cavity (n?=?2). All patients showed clinical deterioration. Procedures for CSF diversion were ventriculoperitoneal shunt (n?=?21), subduroperitoneal shunt (n?=?3), and cystoperitoneal shunt (n?=?2). In patients with lower Karnofsky Performance Score (KPS) (
机译:胶质母细胞瘤患者在病程中可能发生脑脊液(CSF)循环障碍。通常建议进行腹膜-腹膜分流以改善胶质母细胞瘤患者的症状。然而,胶质母细胞瘤患者的分流植入存在复杂的情况,在其他情况下分流会产生不同的问题。关于转移性神经胶质瘤患者并发症的信息很少成为研究的对象。在这项回顾性研究中,我们回顾性分析了十年来连续治疗的一系列患者中分流处理后胶质母细胞瘤相关的脑脊液循环障碍的过程和结果。 2002年至2016年在汉诺威医学院神经外科诊断为723例经病理组织学证实的胶质母细胞瘤的患者中,有30例因脑脊液循环障碍而接受了分流。分析了胶质母细胞瘤的治疗史以及与分流实施相关的所有程序。有关随访,进展时间和生存率的数据可通过查看医院病历表获得,并通过与患者,患者的关系或主治医生的电话访谈来补充。诊断为胶质母细胞瘤时的平均年龄为43岁。确定了五种类型的脑脊液循环障碍:阻塞性脑积水(n?=?9),沟通性脑积水(n?=?15),外部脑积水(n?=?3),侧脑室受困(n?=?1),并扩大切除腔内的液体收集量(n = 2)。所有患者均表现出临床恶化。脑脊液改道的方法是腹膜-腹腔分流(n≥3)和腹膜-腹腔分流(n≥3)和腹膜下分流(n≥2)。在Karnofsky性能评分(KPS)较低(<?60)的患者中,分流植入后中位KPS有显着改善(p?=?0.019)。由于导管阻塞,导管脱位,瓣膜缺损和感染,9例患者必须进行分流翻修(单次翻修,n = 6;多次翻修,n = 3)。在中位随访期88个月中,有28名患者因疾病进展而死亡。诊断为胶质母细胞瘤后的平均总生存时间为10.18?个月。胶质母细胞瘤患者的脑脊液分流面临更多挑战,并增加了并发症的风险,但是这些通常可以通过翻修手术来解决。 CSF分流可暂时改善神经功能,并提高大多数患者的生活质量,尽管尚不清楚生存率是否会提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号